It has been shown that tetrahydroxystilbene glycoside inhibits the associated desferrioxic anemia and ameliorates the pathogenesis of AD in APP/PS1 mice by activating the GSH/GPX4/ROS signaling pathway [135]. This evidence concerns the gene GPX4 and Alzheimer disease.